Investor Relations

Latest Financial Results

Q1 2022

Quarter Ended Mar 31, 2022

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2021

mail icon

Sign Up For Email Alerts

Receive updates straight into your inbox

Sign up today

Company Overview

Sigyn Therapeutics is a development-stage therapeutic technology company headquartered in San Diego, California USA. Our focus is directed toward a significant unmet need in global health; the treatment of life-threatening inflammatory conditions that are precipitated by Cytokine Storm Syndrome and not addressed with an approved therapy. Our mission is to save lives.

Investor Contact Information

Company

Sigyn Therapeutics, Inc.
2468 Historic Decatur Rd.
Suite 140
San Diego, CA 92106
T: (619) 353-0800

Investor Relations

Sigyn Therapeutics
Steven Kilmer
Investor Relations
M: (646) 274-3580
stephen@sigyntherapeutics.com

Russo Partners, LLC
David Schull
Media Relations Contact
T: (212) 845-4271
David.Schull@russopartnersllc.com

Russo Partners, LLC
Nic Johnson
Media Relations Contact
T: (212) 845-4242
Nic.Johnson@russopartnersllc.com

Sigyn Therapeutics
Charlene Owen
General Corporate Inquiries
T: (619) 353-0800
charlene@sigyntherapeutics.com
www.sigyntherapeutics.com

Transfer Agent

VStock Transfer, LLC
18 Lafayette Place
Woodmere, New York 11598
T: (212) 828-8436
F: (646) 536-3179
info@vstocktransfer.com
https://www.vstocktransfer.com/contact